Large PBMs Control 70% of the Market – A Closer Look at Industry Dominance
Tuesday, 10 September 2024, 12:29
Understanding the PBM Market Landscape
Large PBMs control 70% of the market, showcasing significant concentration in the industry. This dominant position affects drug pricing and access for consumers.
Market Share Breakdown
- CVS Health: 21.3%
- OptumRx: 20.8%
- Express Scripts: 17.1%
- Prime Therapeutics: 10.3%
Implications of PBM Control
With such a large share held by these companies, analysts are concerned about the implications for drug pricing and market competition.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.